Metropolitan Hospital; 2Nd Oncology Clinic
About Metropolitan Hospital; 2Nd Oncology Clinic
"Από την ίδρυσή του το 2001, το Metropolitan Hospital καθιερώθηκε σε υψηλή θέση στον κλάδο της ιδιωτικής υγείας. 1.500 ιατροί υψηλού επιστημονικού κύρους και 800 άρτια εκπαιδευμένοι νοσηλευτές, 35.000 ασθενείς για νοσηλεία, 350.000 επισκέπτες κάθε χρόνο στα εξωτερικά ιατρεία, υπερσύγχρονες εγκαταστάσεις, προηγμένος τεχνολογικός εξοπλισμός και συνεργασίες με διεθνή επιστημονικά κέντρα τοποθετούν το Μetropolitan μεταξύ των καλύτερων θεραπευτηρίων της Ευρώπης, με συνεχείς επιτυχίες στην έρευνα και στην εφαρμογή πρωτοποριακών μεθόδων διάγνωσης και θεραπείας. Tο Metropolitan Hospital πρώτο θεραπευτήριο στην Ελλάδα και το τέταρτο παγκοσμίως που απέκτησε την πιστοποίηση EXCELLENCE IN MEDICAL TOURISM του TEMOS Ιnternational."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Genentech, Inc.
1
Clinical Trials at Metropolitan Hospital; 2Nd Oncology Clinic
During the past decade, Metropolitan Hospital; 2Nd Oncology Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
2012-01-11
2022-08-31
Completed
273
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
2020-08-27
2026-12-31
Recruiting
15,000
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Metropolitan Hospital; 2Nd Oncology Clinic
According to Clinical.Site data, the most researched conditions in "Metropolitan Hospital; 2Nd Oncology Clinic" are
"Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials), "Prostate Cancer" (1 trials) and "Solid Tumours" (1 trials). Many other conditions were trialed in "Metropolitan Hospital; 2Nd Oncology Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Metropolitan Hospital; 2Nd Oncology Clinic
Most popular intervention types in "Metropolitan Hospital; 2Nd Oncology Clinic" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "Abiraterone" (1 trials), "Apitolisib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Metropolitan Hospital; 2Nd Oncology Clinic
The vast majority of trials in "Metropolitan Hospital; 2Nd Oncology Clinic" are
5 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Metropolitan Hospital; 2Nd Oncology Clinic
Currently, there are NaN active trials in "Metropolitan Hospital; 2Nd Oncology Clinic".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Metropolitan Hospital; 2Nd Oncology Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Metropolitan Hospital; 2Nd Oncology Clinic, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".